acids in plasma and showed that filterable GAPDH mRNA species are present, and therefore likely to be particle bound, whereas the majority of ␤-globin DNA is not filterable and thus is not particle bound.
Our study analyzed cell-free nucleic acids in amniotic fluid for the presence of particle-associated mRNA species, and like Ng et al. (7 ), we found the greatest decrease in GAPDH mRNA after filtration through a 0.22 m filter, whereas filtration did not significantly reduce the amount of cell-free ␤-globin DNA present. Additionally, this study evaluated the difference in amounts of nucleic acids present in whole amniotic fluid containing cells and the cell-free fraction. Much more ␤-globin DNA could be isolated from whole amniotic fluid than from the cell-free fraction, but there was no statistically significant difference in the amount of GAPDH mRNA that could be isolated from the two fractions.
This study demonstrates similar properties of cell-free nucleic acids in amniotic fluid and in plasma. Ng et al. (7 ) suggested that circulating DNA and RNA in plasma are both protected from degradation by associated particles, but the non-particle-associated form of DNA is less efficiently degraded than the non-particle-associated form of RNA and thus is present in much greater quantities relative to the particle-associated form. We extend this hypothesis to the properties of cell-free nucleic acids in amniotic fluid. These data suggest that in different body fluids, there is a universal mechanism of cell-free nucleic acid processing, possibly via packaging during apoptosis.
To our knowledge, this is the first study to evaluate the properties of cell-free mRNA in amniotic fluid. We have also studied fetal gene expression in amniotic fluid (12 ) . More research is needed to further evaluate the origin and kinetics of cell-free nucleic acids in amniotic fluid as this material has significant clinical potential for the study of health and development in living fetuses. Circulating DNA is increased in various benign and malignant pathologic conditions, including cancers, sepsis, and graft-vs-host and autoimmune diseases as well as after trauma or ischemia (1) (2) (3) (4) (5) (6) (7) (8) . Changes in circulating DNA correlate with the response to antitumor therapy and with tumor recurrence (9 -11 ) . Furthermore, DNA concentration reportedly has predictive and prognostic relevance in cancer (11, 12 ) . Despite the nonspecific nature of circulating DNA, it might have considerable potential for monitoring cancer and management of therapy (9 -12 ) .
Stability of Nucleosomal
In serum and plasma, DNA is thought to exist predominantly as mono-and oligonucleosomes (13, 14 ) , which are formed by a core particle of a double set of the histones H2A, H2B, H3, and H4 wrapped by 146 bp of DNA on the outside (15 ) . By this composition they seem to be protected against rapid digestion by endonucleases (16 ) . Circulating nucleosomes can be quantified by realtime PCR of the DNA but also by immunologic assays, which are particularly well suited for serial measurements (17 ) .
Achieving reliable results in these immunochemical assays requires adherence to a strict preanalytical protocol that includes careful venipuncture, centrifugation of the (A-F), serum samples were stabilized with 10 mmol/L EDTA, aliquoted, and incubated for 1, 2, 3, 4, 6, and 24 h and 2, 3, and 7 days, respectively, at 4, 25, and 37°C, respectively, before storage at Ϫ70°C and nucleosome measurement. Samples showed only minor changes when incubated at 4 and 25°C, whereas a considerable decrease was observed after incubation at 37°C. (G and H), stabilized sera were vortex-mixed for 5, 10, and 30 s or, alternatively, rolled in an overhead roller for 15 and 30 min. They were then stored at 25 or at 37°C for 4 h before being frozen at Ϫ70°C. Neither shaking nor rolling influenced the measured nucleosome concentrations, but after incubation at 37°C, the measured concentrations were lower. (I), stabilized sera underwent several freeze-thaw cycles before nucleosome measurements. (J), deep-frozen sera were thawed 2 and 12 h before measurement and were, meanwhile, stored at 4 and 25°C. Freezing-thawing had no impact on nucleosome concentrations.
Clinical Chemistry 51, No. 6, 2005 sample within 1-2 h after venipuncture, addition of EDTA for stabilization of nucleosomes, and storage at Ϫ70°C if measurement is to be delayed. This procedure is based on our earlier studies on preanalytical factors that could influence the nucleosome concentrations between venipuncture and centrifugation, between centrifugation and EDTA addition, between EDTA addition and freezing, during long-term storage, and between thawing and test performance (17 ) . Our results indicated that a delay between venipuncture and centrifugation can lead to a time-dependent increase in nucleosome concentrations, which was most pronounced at 37°C, whereas a delay in EDTA addition after centrifugation was associated with a time-dependent decrease in results (17 ) .
In many instances, blood samples are transported to the laboratory by mail; we therefore investigated various additional preanalytical conditions that might influence the stability of nucleosomes in serum during shipping: Sera from 5 volunteers were exposed to prolonged time of transportation, different temperatures, shaking and rolling, several freeze-thaw cycles, and measurements with various delays after thawing. In all experiments, the samples were centrifuged, within 30 min after venipuncture, at 3000g for 15 min and stabilized with 10 mmol/L EDTA (pH 8) immediately after centrifugation. Subsequently, they were aliquoted, and methodical experiments were performed. They were then stored at Ϫ70°C and analyzed in batches containing all samples from a single patient.
The nucleosome ELISA (Cell Death Detection ELISA plus ; Roche Diagnostics) is based on a quantitative sandwich enzyme immunoassay principle: Monoclonal mouse antibodies directed against DNA (single-and doublestranded DNA) and histones (H1, H2A, H2B, H3, and H4) detect specifically mono-and oligonucleosomes. The antihistone antibody is bound to the microtiter plate, whereas the anti-DNA antibody labeled with peroxidase reacts with 2,2Ј-azino-di(3-ethylbenzthiazoline-sulfonate). The amount of captured nucleosomes is proportional to the resulting color development and enables spectrophotometric quantification in arbitrary units (17 ) .
In the first experiment, we varied the time between stabilization of the sera with EDTA and storage at Ϫ70°C (1, 2, 3, 4, 6 , and 24 h and 2, 3, and 7 days), and samples were stored at various temperatures during that time (4, 25, and 37°C) to simulate potential stressful transportation conditions. Prolonged "transportation time" clearly did not influence the values in those stabilized sera that were stored at 4 and 25°C. The median SD for all time points was Ͻ10%. At 37°C, however, the values decreased continually, and after 24 h, only approximately one-half of the initial concentration remained (median SD, 50.2%; Fig. 1, A-F) .
In the second experiment, we investigated the influence of agitation by vortex-mixing the samples for 5, 10, and 30 s or, alternatively, by rolling them in a slow overhead roller for 15 and 30 min. Subsequently, all of the samples were incubated at 25 or 37°C for 4 h before they were frozen at Ϫ70°C. Neither after shaking nor after rolling the samples did we observe major changes in the concentrations of stabilized sera, particularly if they were incubated at 25°C for 4 h (median SD Ͻ5%). However, after additional incubation at 37°C for 4 h, the values tended to be lower (median SD up to 20%; Fig. 1, G and H) .
We then analyzed the influence of freezing and thawing on the stabilized sera. Repeated refreezing (up to 3 times at Ϫ70°C) led to only minor changes in the concentrations (median SD Ͻ10%). Thawing the samples at various time points before measurements (2 and 12 h) and storage at various temperatures (4 and 25°C) also had no impact on the values (median SD Ͻ10%; Fig. 1, I and J).
Our results indicate that the concentration of nucleosomes in sera stabilized with 10 mmol/L EDTA is not influenced by preanalytical conditions such as time of transportation, moderate temperature (4 -25°C), shaking, rolling, and several freeze-thaw cycles. However, longterm exposure to high temperatures (37°C) should be avoided as it can cause a notable decrease in the measured nucleosome concentration. This might be attributable to enhanced activation of serum nucleases or by direct thermal damage of the nucleosomes.
When these precautions are taken and the preanalytical protocol is followed, including early centrifugation and subsequent stabilization of the sera with EDTA, samples can be shipped by mail without adverse effects on the results of nucleosome measurements.
The nucleosome assays were provided by Roche Diagnostics, Germany. Protein arrays typically consist of a capture protein on a matrix, e.g., glass slide, silicon chip, or coded microparticle (1 ). The latter minimizes steric constraints and enhances reaction kinetics (2 ). Microarray technologies have been used for detecting allergens (3 ) and cytokines (4 ) . A primary advantage of microarray technologies over conventional immunoassays is the ability to multiplex assays.
Relative Quantification of Experimental
Currently, ELISA is the method of choice for autoantibody detection (5 ) . This method, however, is labor-intensive and requires comparatively large sample and reaction volumes. Nonetheless, ELISAs are currently performed to aid differential diagnosis of certain autoimmune diseases. Dermatomyositis (6 ) is characterized by detection of anti-Jo-1 IgG in patient sera. Both anti-Sm and anti-RNP/Sm IgGs are indicative of systemic lupus erythematosus (7 ) . The presence of anti-Scl70 IgGs aids diagnosis of systemic sclerosis (8 ) . Anti-SSB and -SSA IgGs are present in systemic lupus erythematosus (9 ) or Sjö gren syndrome (10 ) . With microarray technologies, all these autoantibodies can be screened simultaneously.
The Luminex particle array platform comprises a hundred microparticles, each possessing a distinct fluorescent signature generated by a blend of two internal fluorescent dyes. Capture protein is conjugated to the bead surface, to assay for the cognate entity within a single reaction vessel. The instrument includes a microfluidics system and two lasers. A 635 nm laser excites the red and infrared classifier fluorophores that form the particular signature of each bead set. The second laser (523 nm) excites phycoerythrin dye used as a molecular tag for detection. Detection of cytokines (11 ) , cancer markers, and allergens (12 ) has been reported.
Use of internal calibration curves for cytokine quantification has been documented (13 ), but with antigen arrays, quantification is more difficult because of the time and expense required for antibody synthesis. Where quantification of antibodies has been cited, competitive immunoassays are described that use labeled forms of the target analyte specifically tailored for the particular assays described (14 ) . Assays for quantifying total immunoglobulin content have also been described (15 ), but not in the context of creating a reference material for a specific antibody within the same class of immunoglobulins.
Commercial Luminex-based assays for autoantibodies are available, e.g., from Linco Research and Zeus Scientific. These tests are qualitative, however, and do not allow for direct comparisons between assays. In this report we describe a set of internal standards for antigen arrays that enable interassay comparisons by creating a point of reference for the detection of human IgG. Relative quantification would enable monitoring of treatment administered to combat disease.
We illustrate the use of an internal IgG calibration curve and the detection of six autoantibodies: Jo-1 IgG, Sm IgG, Scl-70 IgG, RNP/Sm IgG, SSB/La IgG and SSA/Ro IgG in patient serum samples. Recombinant forms of the cognate antigens (5 mg/L in phosphate-buffered saline, pH 7.4; AroTec Diagnostics Ltd.) were coupled to the surface of Luminex xMap TM carboxylated microspheres according to the manufacturer's instructions. Within the multiplex, ϳ10 000 of each antigen-coupled bead set were challenged with serum diluted 1 in 300 (50 L), obtained from Genesis Diagnostics. To assess the scope for quantification, we used 22 serum samples. Each reaction mixture was agitated at room temperature for 1 h. Tubes were microcentrifuged for 1 min, and the resulting supernatant was discarded. Beads were washed three times with protein array wash buffer [50 L; phosphate-buffered saline (pH 7.4), containing 10 g/L bovine serum albumin, 0.2 g/L Tween 20, and 0.2 g/L sodium azide; Sigma]. The beads were incubated with biotinylated sheep anti-human IgG antibody (Amersham Pharmacia Biotech UK) diluted 1 in 10 000 (100 L) and mixed for 1 h at room temperature. Beads were washed before incubation with streptavidin-conjugated phycoerythrin (400 ng/100 L; Molecular Probes) for 30 min at room temperature. Tubes were foil-wrapped to prevent photobleaching of beads. Beads were washed before injection into the Luminex instrument, in which a minimum of 100 events per bead set were analyzed. Serum was designated as positive if the fluorescent output was greater than the upper 95% confidence interval of the single "normal" (nondisease state) serum sample included in each assay. The negative control contained antigen-conjugated bead sets treated with protein array buffer.
To quantify the analytes relative to a reference point, 11 sets of calibration beads were synthesized and incorporated into the assay. These comprise microspheres conjugated to known quantities of purified human IgG, ranging from 10 ng/L to 250 mg/L, to construct the calibration curve.
Three experiments were performed, each with triplicate determinations. Mean values, 95% confidence intervals, and CVs were determined with Microsoft Excel 97. Twoway ANOVAs (Statistica, Ver. 6; StatSoft) were applied.
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